These insights implied the possibility that the NRF3-RAB5-macropinocytosis axis paradoxically interferes with obesity-induced cancer development through attenuation of obesity-induced inflammation and resistance to therapy targeting cancer anabolism (Figure 4). The gene discussed is RAB5A; the disease is obesity disorder.